These novel medications , Tirzepatide , represent a groundbreaking advancement in treating obesity and potentially related ailments . These drugs are grouped as GLP-1 receptor stimulators, signifying they function to replicate the endogenous GLP-1 peptide, boosting insulin release and lowering appetite . While Retatrutide every works largely simila